IVF Services Market

Market Definition

The global IVF Services Market size valued to USD 13.63 billion in 2019, shall elevate to USD 35.53 billion by 2030, witnessing a CAGR of 9.1% from 2020-2030.

IVF (In Vitro Fertilization) is a type of Assisted Reproductive Technology (ART), where female ovum retrieved from the ovaries fertilize with quality male sperm, under artificial laboratory conditions, in a vitro (glass), and develop into a zygote. Once the zygote undergoes embryo culture, the practitioner implants it into the female uterus, with an intention of establishing a successful pregnancy. It is the most common type of ART to treat infertility in male-female and assist gestational surrogacy. Single parent and LGBT community widely adopt it to procreate.

Market Dynamics and Trends

The global IVF services market is driven by factors such as rise global infertility rates, delayed pregnancies, increased gamete donations, rise in same-gender marriages, increased number of gestational surrogacies and increasing disposable incomes. Besides, changing lifestyles, food-habits, rising levels of stress, increased consumption of alcohol, surge in cigarette-smoking, increasing incidences of infertility disease in male-female and obesity, are to boost the IVF services market growth significantly during the forecast period.

However, factors such as less awareness towards IVF treatment, society restraints, cost constraints associated with the procedure and complications related to the IVF procedure, may impede the IVF services market growth during the forecast period.

Moreover, technological advancements associated with IVF devices, modernizing healthcare infrastructures, increase in IVF clinics, surge in fertility tourism specifically in the emerging economies, and high success rate of the IVF treatment are to create lucrative opportunities in the global IVF services market, in coming future.

The global IVF services market share analysis is based on cycle type, end user, and geography.
Based on the type of cycle, the market is divided into Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles. Based on end user, the market is bifurcated into Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.

North America is expected to dominate the global IVF services market throughout the fore-cast period owing to the increased adoption of IVF services over the forecast period. Besides, advancement in IVF technologies, blooming healthcare facilities and rise in infertility rates among the youth, are the major factors to drive the market growth during the forecast period.

It is anticipated that the Asia Pacific region shall show a significant growth, holding moderate market share over the forecast period. Furthermore, cumulative success rate of the IVF treatments, increase in the number of fertility clinics and proliferating fertility tourism, is expected to boost the growth of IVF services market.

The highly competitive IVF services market consists of various market players. Some of the major market players are Cologne GmbH, amedes MVZ, AVA Clinic Scanfert, AMP Center St Roch, Bangkok IVF center (Bangkok Hospital), Biofertility Center, Betamedics, Bourn Hall Fertility Center, Bloom Fertility Center, Center for Advanced Reproductive Medicine and Infertility, Ambroise Paré Group, Cardone Reproductive Medicine and Infertility, LLC, Chelsea and Westminster Hospital (Assisted Conception Unit), Cloudnine Fertility and CHA Fertility Center among others.

The past endeavors, present developments and futuristic advancements, sum-up to comprehend the overall growth of the global IVF services market.For instance, in January 2020, the Bourn hall fertility clinic announced a ‘systems medicine approach’ to improve fertility medicine, creating opportunities for personalized IVF treatment.

Moreover, in January 2020, the NSW Government committed an investment of $42 million for the IVF services, making fertility treatment much more affordable for up to 6,000 women, in the NSW publicly supported IVF clinics.

Key Benefits

• The IVF services market report provides a quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.

• The study comprises a deep dive analysis of the IVF services market trend including the current and future trends for depicting prevalent investment pockets in the market.

• The report provides an in-depth analysis of current research and clinical developments within global IVF services market along with key market dynamic factors that help in understanding the behavior of market.

• The report gives detailed information related to key drivers, restraints, opportunities and their impact on the IVF services market.

• The report incorporates a competitive analysis of the market players along with their market share in the global IVF services market.

• The study elaborates SWOT analysis and Porters Five Forces model for the IVF services market.

• Value chain analysis in the IVF services market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Cycle Type

• Fresh IVF Cycles (Non-donor)

• Thawed IVF Cycles (Non-donor)

• Donor Egg IVF Cycles

By End User

• Fertility Clinics

• Hospitals

• Surgical Centers

• Clinical Research Institutes

By Geography

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Rest of Europe

• Asia-Pacific

  • China

  • India

  • Japan

  • Australia

  • Rest of Asia-Pacific

• RoW

  • UAE

  • Saudi Arabia

  • South Africa

  • Brazil

  • Remaining countries

KEY PLAYERS:

• amedes MVZ Cologne GmbH

• Ambroise Paré Group

• AVA Clinic Scanfert

• AMP Center St Roch

• Bangkok IVF center (Bangkok Hospital)

• Biofertility Center

• Betamedics

• Bourn Hall Fertility Center

• Bloom Fertility Center

• Center for Advanced Reproductive Medicine and Infertility

• Cardone Reproductive Medicine and Infertility, LLC

• Chelsea and Westminster Hospital (Assisted Conception Unit)

• Cloudnine Fertility

• CHA Fertility Center

REPORT SCOPE AND SEGMENTATION: